<DOC>
	<DOCNO>NCT02421679</DOCNO>
	<brief_summary>This 12-week , multicenter , open-label extension study evaluate safety efficacy TNX-102 SL tablet take daily bedtime patient Military-Related PTSD related condition . Patients recruit trial successfully complete double-blind study , TNX-CY-P201 ( AtEase Study ) . Patients make aware therapy receive double-blind study .</brief_summary>
	<brief_title>Open Label Extension Safety Efficacy Study TNX-102 SL Tablets Military Related PTSD Related Conditions</brief_title>
	<detailed_description>The study consist 4 clinic visit , include Screening/Baseline Visit 1 ( Day 0 , anticipate date final visit lead-in P201 study ) visit 2 , 6 12 week treatment . The previous requirement lead-in study refrain use certain concomitant medication trauma-focused psychotherapy relax . Patients may continue take rescue therapy sleep , appropriate , may utilize medication need help sleep , per judgment investigator . Eligible patient provide write informed consent take one TNX-102 SL tablet daily bedtime sublingually ( tongue ) 12 week . All patient assign receive tthe dosage TNX-102 SL , regardless treatment assignment lead-in study . No patient , investigator , study staff know assign study treatment lead-in study , P201 , time entry extension study . Patient data collect Week 12 visit ( Visit 9 ) lead-in P201 study use one baseline value study .</detailed_description>
	<mesh_term>Cyclobenzaprine</mesh_term>
	<criteria>Completed leadin study judge reasonably compliant , least 60 % compliance Signed informed consent Met prior inclusion exclusion requirement leadin study No new worsen medical condition since start leadin study could pose safety risk interfere participation study Willing refrain use specific medication ( ask PI ) Female patient childbearing potential continue practice medically acceptable method birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Military-related PTSD related condition</keyword>
	<keyword>open-label extension</keyword>
</DOC>